RUA Life Sciences PLC - Ayrshire, Scotland-based medical device business - Notes findings from heart valve testing of Elast-Eon polymers. Says all valves tested "easily surpassed minimum ISO requirements" which means product can work on human hearts. Notes valves tested showed "remarkable consistency in performance". "The RUA surgical valve and Elast-Eon leaflet system have been designed to minimise stress with the objective of increasing the durability of heart valves," RUA says.
Current stock price: 150.00 pence
Year-to-date change: up 49%
By Eric Cunha; ericcunha@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.


(Sharecast News) - RUA Life Sciences said in an update on Friday that it expected to report a smaller EBITDA loss, broadly reaching breakeven on an ad...


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: